This inventor holds 2 USPTO granted patents. Top assignee: Kureha Kagaku Kogyo Kabushiki Kaisha. Active years: 1987-1988.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1987-1988
Title: Yoko Onishi: Innovator in Pharmaceutical Chemistry
Introduction
Yoko Onishi is a prominent inventor based in Mitaka, Japan. She has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of cephalosporin derivatives. With a total of 2 patents, her work has had a notable impact on antibacterial agents and pharmaceutical compositions.
Latest Patents
Onishi's latest patents include a cephalosporin derivative and a process for producing the same. The first patent discloses a cephalosporin derivative represented by a specific formula, wherein R¹ represents a halogenoalkyl group, along with a salt and ester thereof. This invention also encompasses a pharmaceutical composition and an antibacterial agent comprising the cephalosporin derivative. The second patent details a compound known as 7-beta-[2-(2-amino-4-thiazolyl)-2-methoxyiminoacetamido]-3-(2-amino-1,3,4-thiadiazolyl-5-thiomethyl)-3-cepheme-4-carboxylic acid, including its salts and pivaloyloxymethyl ester, as well as a pharmaceutical composition containing this compound as an active ingredient.
Career Highlights
Yoko Onishi is associated with Kureha Kagaku Kogyo Kabushiki Kaisha, a company known for its innovative approaches in chemical manufacturing. Her work at this organization has allowed her to focus on the development of new pharmaceutical products that address critical health issues.
Collaborations
Onishi has collaborated with notable coworkers such as Shigeaki Muto and Takao Ando. These partnerships have contributed to her success in the field and have fostered a collaborative environment for innovation.
Conclusion
Yoko Onishi's contributions to pharmaceutical chemistry, particularly through her patents, highlight her role as an influential inventor. Her work continues to advance the field and improve healthcare solutions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
